Wolf Wiedemeyer

Company: BridGene Biosciences Inc.

Job title: Director - Biology

Seminars:

A Covalent TEAD Inhibitor with Exceptional Anti-cancer Activity & Combination Potential 2:15 pm

Presenting preclinical updates on a lead covalent TEADi including in vivo efficacy Harnessing TEAD selectivity to expand into TEADi-responsive indications Exploring combination approaches with KRASiRead more

day: Conference Day One